Kronos Bio, Inc. Retained Earnings
Kronos Bio, Inc. had Retained Earnings of -$603.30 million as of 2025-03-31, per its 10-Q filed 2025-05-08.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2025-05-08
- 2025-03-31: Retained Earnings (Accumulated Deficit) -$603.30M.
- 2024-12-31: Retained Earnings (Accumulated Deficit) -$594.94M.
- 2024-09-30: Retained Earnings (Accumulated Deficit) -$569.13M.
- 2024-06-30: Retained Earnings (Accumulated Deficit) -$555.02M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2025-03-31 | -$603.30M 10-Q · filed 2025-05-08 |
| 2024-12-31 | -$594.94M 10-Q · filed 2025-05-08 |
| 2024-09-30 | -$569.13M 10-Q · filed 2024-11-13 |
| 2024-06-30 | -$555.02M 10-Q · filed 2024-08-08 |
| 2024-03-31 | -$538.82M 10-Q · filed 2024-05-09 |
| 2023-12-31 | -$508.86M 10-K · filed 2025-03-18 |
| 2023-09-30 | -$483.54M 10-Q · filed 2023-11-13 |
| 2023-06-30 | -$452.17M 10-Q · filed 2023-08-08 |
| 2023-03-31 | -$422.43M 10-Q · filed 2023-05-10 |
| 2022-12-31 | -$396.19M 10-K · filed 2024-03-21 |
| 2022-09-30 | -$364.41M 10-Q · filed 2022-11-08 |
| 2022-06-30 | -$332.15M 10-Q · filed 2022-08-04 |
| 2022-03-31 | -$299.25M 10-Q · filed 2022-05-04 |
| 2021-12-31 | -$262.98M 10-K · filed 2023-03-15 |
| 2021-09-30 | -$200.65M 10-Q · filed 2021-11-09 |
| 2021-06-30 | -$167.05M 10-Q · filed 2021-08-12 |
| 2021-03-31 | -$137.99M 10-Q · filed 2021-05-11 |
| 2020-12-31 | -$111.91M 10-K · filed 2022-02-24 |
| 2020-09-30 | -$78.75M 10-Q · filed 2020-11-18 |
| 2019-12-31 | -$23.46M 10-K · filed 2021-03-23 |